A citation-based method for searching scientific literature

Stephanie A Cohen, Dawn McIlvried, Julie Schnieders. J Genet Couns 2009
Times Cited: 17







List of co-cited articles
105 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors.
Bronson D Riley, Julie O Culver, C├ęcile Skrzynia, Leigha A Senter, June A Peters, Josephine W Costalas, Faith Callif-Daley, Sherry C Grumet, Katherine S Hunt, Rebecca S Nagy,[...]. J Genet Couns 2012
180
47

American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.
Mark E Robson, Courtney D Storm, Jeffrey Weitzel, Dana S Wollins, Kenneth Offit. J Clin Oncol 2010
293
41


Cancer genetic risk assessment and referral patterns in primary care.
Hetal S Vig, Joanne Armstrong, Brian L Egleston, Carla Mazar, Michele Toscano, Angela R Bradbury, Mary B Daly, Neal J Meropol. Genet Test Mol Biomarkers 2009
40
41

Genetic testing and cancer risk management recommendations by physicians for at-risk relatives.
Sharon E Plon, H Paul Cooper, Bethany Parks, Shweta U Dhar, P Adam Kelly, Armin D Weinberg, Stephanie Staggs, Tao Wang, Susan Hilsenbeck. Genet Med 2011
77
41

Assessment of clinical practices among cancer genetic counselors.
Deborah Wham, Thuy Vu, Gayun Chan-Smutko, Christine Kobelka, Diana Urbauer, Brandie Heald. Fam Cancer 2010
41
35

Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians.
Cecelia A Bellcross, Katherine Kolor, Katrina A B Goddard, Ralph J Coates, Michele Reyes, Muin J Khoury. Am J Prev Med 2011
108
29

Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors.
Angela Trepanier, Mary Ahrens, Wendy McKinnon, June Peters, Jill Stopfer, Sherry Campbell Grumet, Susan Manley, Julie O Culver, Ronald Acton, Joy Larsen-Haidle,[...]. J Genet Couns 2004
143
23

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
23

Errors in delivery of cancer genetics services: implications for practice.
Karina L Brierley, Danielle Campfield, Whitney Ducaine, Lindsay Dohany, Talia Donenberg, Kristen Shannon, Robin C Schwartz, Ellen T Matloff. Conn Med 2010
64
23


Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
23

Physicians' experiences with BRCA1/2 testing in community settings.
Nancy L Keating, Kathryn A Stoeckert, Meredith M Regan, Lisa DiGianni, Judy E Garber. J Clin Oncol 2008
31
23

Report from the National Society of Genetic Counselors service delivery model task force: a proposal to define models, components, and modes of referral.
Stephanie A Cohen, Shanna L Gustafson, Monica L Marvin, Bronson D Riley, Wendy R Uhlmann, S Bonnie Liebers, Julie A Rousseau. J Genet Couns 2012
42
23

Identification of genetic counseling service delivery models in practice: a report from the NSGC Service Delivery Model Task Force.
Stephanie A Cohen, Monica L Marvin, Bronson D Riley, Hetal S Vig, Julie A Rousseau, Shanna L Gustafson. J Genet Couns 2013
72
23

Modes of delivery of genetic testing services and the uptake of cancer risk management strategies in BRCA1 and BRCA2 carriers.
T Pal, J-H Lee, A Besharat, Z Thompson, A N A Monteiro, C Phelan, J M Lancaster, K Metcalfe, T A Sellers, S Vadaparampil,[...]. Clin Genet 2014
22
23

A statewide survey of practitioners to assess knowledge and clinical practices regarding hereditary breast and ovarian cancer.
Tuya Pal, Deborah Cragun, Courtney Lewis, Andrea Doty, Maria Rodriguez, Cristi Radford, Zachary Thompson, Jongphil Kim, Susan T Vadaparampil. Genet Test Mol Biomarkers 2013
39
23


American Society of Clinical Oncology policy statement: the role of the oncologist in cancer prevention and risk assessment.
Robin T Zon, Elizabeth Goss, Victor G Vogel, Rowan T Chlebowski, Ismail Jatoi, Mark E Robson, Dana S Wollins, Judy E Garber, Powel Brown, Barnett S Kramer. J Clin Oncol 2009
41
17

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.
S A Narod, J S Brunet, P Ghadirian, M Robson, K Heimdal, S L Neuhausen, D Stoppa-Lyonnet, C Lerman, B Pasini, P de los Rios,[...]. Lancet 2000
385
17

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.
Peter C Fong, David S Boss, Timothy A Yap, Andrew Tutt, Peijun Wu, Marja Mergui-Roelvink, Peter Mortimer, Helen Swaisland, Alan Lau, Mark J O'Connor,[...]. N Engl J Med 2009
17

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
690
17

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
Amy Finch, Mario Beiner, Jan Lubinski, Henry T Lynch, Pal Moller, Barry Rosen, Joan Murphy, Parviz Ghadirian, Eitan Friedman, William D Foulkes,[...]. JAMA 2006
384
17



Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trial.
Beth N Peshkin, Tiffani A Demarco, Kristi D Graves, Karen Brown, Rachel H Nusbaum, Diana Moglia, Andrea Forman, Heiddis Valdimarsdottir, Marc D Schwartz. Genet Test 2008
42
17


Delivery of Internet-based cancer genetic counselling services to patients' homes: a feasibility study.
Neal J Meropol, Mary B Daly, Hetal S Vig, Frank J Manion, Sharon L Manne, Carla Mazar, Camara Murphy, Nicholas Solarino, Vadim Zubarev. J Telemed Telecare 2011
33
17

Clinical genetics issues encountered by family physicians.
Louise S Acheson, Kurt C Stange, Stephen Zyzanski. Genet Med 2005
42
17


Physician use of genetic testing for cancer susceptibility: results of a national survey.
Louise Wideroff, Andrew N Freedman, Lorayn Olson, Carrie N Klabunde, William Davis, Kadaba P Srinath, Robert T Croyle, Rachel Ballard-Barbash. Cancer Epidemiol Biomarkers Prev 2003
103
17

Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.
Douglas E Levy, Stacey D Byfield, Catherine B Comstock, Judy E Garber, Sapna Syngal, William H Crown, Alexandra E Shields. Genet Med 2011
149
17

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
Tuya Pal, Jenny Permuth-Wey, Judith A Betts, Jeffrey P Krischer, James Fiorica, Hector Arango, James LaPolla, Mitchell Hoffman, Martin A Martino, Katie Wakeley,[...]. Cancer 2005
487
17

Oncology nurses' knowledge, practice, and educational needs regarding cancer genetics.
S K Peterson, P T Rieger, S K Marani, C deMoor, E R Gritz. Am J Med Genet 2001
21
17

Clinical genetics provider real-time workflow study.
Elizabeth McPherson, Christina Zaleski, Katrina Benishek, Catherine A McCarty, Philip F Giampietro, Kara Reynolds, Kristen Rasmussen. Genet Med 2008
40
17


Personalized cancer genetics training for personalized medicine: improving community-based healthcare through a genetically literate workforce.
Kathleen R Blazer, Deborah J Macdonald, Julie O Culver, Carin R Huizenga, Robert J Morgan, Gwen C Uman, Jeffrey N Weitzel. Genet Med 2011
26
17

Genetic/familial high-risk assessment: breast and ovarian, version 1.2014.
Mary B Daly, Robert Pilarski, Jennifer E Axilbund, Saundra S Buys, Beth Crawford, Susan Friedman, Judy E Garber, Carolyn Horton, Virginia Kaklamani, Catherine Klein,[...]. J Natl Compr Canc Netw 2014
91
17

Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians.
L Wideroff, S T Vadaparampil, M H Greene, S Taplin, L Olson, A N Freedman. J Med Genet 2005
108
17

Evaluation of a breast/ovarian cancer genetics referral screening tool in a mammography population.
Cecelia A Bellcross, Amy A Lemke, Laura S Pape, Angela L Tess, Lorraine T Meisner. Genet Med 2009
65
17


Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, Mary Putt. JAMA 2005
274
17



American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
283
17


Practical aspects of delivering hereditary cancer risk counseling.
Tiffani A DeMarco, Karen L Smith, Rachel H Nusbaum, Beth N Peshkin, Marc D Schwartz, Claudine Isaacs. Semin Oncol 2007
18
11

Barriers to access: results from focus groups to identify genetic service needs in the community.
Rosalyn Y Beene-Harris, Catharine Wang, Janice V Bach. Community Genet 2007
21
11

Delivering cancer genetics services--new ways of working.
Ros Eeles, Glyn Purland, Jane Maher, D Gareth Evans. Fam Cancer 2007
11
18

Educating health-care professionals about genetics and genomics.
Alan E Guttmacher, Mary E Porteous, Joseph D McInerney. Nat Rev Genet 2007
194
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.